Here, a pathway is described in which the fibroblast growth factor receptor 1 (FGFR1) activated by FGF1-derived from cancer-associated fibroblasts (CAFs) is augmenting the tumor cell intrinsic MYC signal [36]. The gene discussed is FGFR1; the disease is cancer.